Package Leaflet: Information for the Patient
Entecavir Sandoz 0.5 mg Film-Coated Tablets EFG
entecavir
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Entecavirisanantiviralmedicineusedtotreatchronic(long-term)hepatitisBvirus(HBV)infectioninadults.
Entecavir may be used in patients whose liver is damaged but still works adequately (compensated liver disease) and in patients whose liver is damaged and does not work adequately (decompensated liver disease).
Entecavirisalsousedtotreatchronic(long-term)HBVinfectioninchildrenandadolescentsfrom2tolessthan18yearsofage.
Entecavir may be used in children whose liver is damaged but still works adequately (compensated liver disease).
Hepatitis B virus infection can damage your liver. Entecavir reduces the amount of virus in your body and improves the condition of your liver.
Do not take Entecavir Sandoz
Warnings and precautions
Talk to your doctor or pharmacist before starting entecavir.
Children and adolescents
Entecavir should not be used in children under 2 years of age or weighing less than 10 kg.
Using Entecavir Sandoz with other medicines
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.
Taking Entecavir Sandoz with food and drinks
In most cases, you can take entecavir with or without food. However, if you have received previous treatment with another medicine containing lamivudine as an active ingredient, you should consider the following. If you have switched to entecavir because lamivudine treatment was not successful, you should take entecavir on an empty stomach, once a day. If your liver disease is very advanced, your doctor will also instruct you on taking entecavir on an empty stomach.
Empty stomach means at least 2 hours after and 2 hours before the next meal.
Children and adolescents (from 2 to less than 18 years of age) can take entecavir with or without food.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. It is not known if the use of entecavir is safe during pregnancy. Entecavir should not be used during pregnancy unless clearly necessary, as determined by your doctor. It is important that women of childbearing age using entecavir use an effective method of contraception to prevent pregnancy.
You should not breastfeed during treatment with entecavir. If you are breastfeeding, tell your doctor. It is not known if entecavir, the active ingredient of Entecavir Sandoz, is excreted in breast milk.
Driving and using machines
Dizziness, fatigue, and somnolence are common side effects that may affect your ability to drive and use machines. If you are affected, do not drive or operate machinery.
This medicine contains lactose
If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.
Not all patients need to take the same dose of entecavir.
Always take this medicine exactly as your doctor has told you. If you are not sure, check with your doctor or pharmacist.
For adults, the recommended dose is 0.5 mg or 1 mg once a day (by mouth).
Your dose will depend on:
For children and adolescents(from 2 to less than 18 years of age), your pediatrician will decide on the appropriate dose based on the child's body weight. Children weighing at least 32.6 kg can take the oral solution or 0.5 mg tablets. Entecavir oral solution is recommended for patients weighing between 10 kg and 32.5 kg. All doses should be taken once a day (by mouth). There are no recommendations for entecavir in children under 2 years of age or weighing less than 10 kg. Your child's doctor will decide on the correct dose based on your child's weight.
Your doctor will advise you on the correct dose for you. Always take the dose recommended by your doctor to ensure the medicine is fully effective and to reduce the development of resistance to treatment. Take entecavir for as long as your doctor tells you. Your doctor will tell you when to stop treatment.
Some patients need to take this medicine on an empty stomach (see Taking Entecavir Sandoz with food and drinksin Section 2). If your doctor tells you to take this medicine on an empty stomach, empty stomach means at least 2 hours after a meal and 2 hours before the next meal.
If you take more Entecavir Sandoz than you should
If you have taken more entecavir than you should, talk to your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount used.
If you forget to take Entecavir Sandoz
It is important that you do not miss any dose. If you miss a dose of Entecavir, take it as soon as you remember and then take the next dose at the usual time. If it is almost time for your next dose, do not take the missed dose. Wait and take the next dose at the usual time. Do not take a double dose to make up for missed doses.
Do not stop taking Entecavir Sandoz without talking to your doctor
Some people develop severe hepatitis symptoms when they stop taking entecavir. Tell your doctor immediately if you notice any changes in your symptoms after stopping treatment.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Adults
Patients treated with entecavir have reported the following side effects:
Children and adolescents
The side effects experienced in children and adolescents are similar to those experienced in adults, with the following difference:
Reporting of side effects
If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Spanish Medicines Monitoring System for Human Use: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton, blister, or bottle after EXP.
The expiry date refers to the last day of the month stated.
This medicine does not require any special storage conditions.
After opening the bottle, use within 6 months.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.
What Entecavir Sandoz contains
Tablet core: lactose monohydrate, microcrystalline cellulose, crospovidone (Type A), and magnesium stearate.
Film coating: hypromellose 2910, macrogol 6000, titanium dioxide (E171), talc.
Appearance and packaging
Film-coated tablet, white, round, marked on both sides with "SZ" on one face and "108" on the other, with a diameter of approximately 8.0 mm.
The film-coated tablets are packaged in OPA/Aluminum/PVC-Aluminum blisters or in an HDPE bottle with a child-resistant polypropylene cap, inserted in a carton.
Pack sizes:
Blister: 30 and 90 film-coated tablets.
Bottle: 30 film-coated tablets.
Not all pack sizes may be marketed in your country.
Marketing authorization holder and manufacturer
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Manufacturer
Lek Pharmaceuticals d.d.
Verovškova ulica 57
1526 Ljubljana
Slovenia
or
Lek Pharmaceuticals d.d.
Trimlini 2d
9220 Lendava
Slovenia
This medicine is authorized in the Member States of the European Economic Area under the following names
Netherlands: Entecavir Sandoz 0.5 mg, filmomhulde tabletten
Italy: Entecavir Sandoz
Norway: Entecavir Sandoz 0.5 mg, filmomhulde tabletten
Poland: Entecavir Sandoz, 0.5 mg, tabletki powlekane
Romania: Entecavir Sandoz 0.5 mg comprimate filmate
Sweden: Entecavir Sandoz 0.5 mg filmdragerade tabletter
Date of last revision of this leaflet: February 2021.
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/